# GlaxoSmithKline, LLC. – FDA Inspection, Jan 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/0b5167aa-cc71-4870-ab00-b2a540d138b4
Source feed: FDA_Inspections

> FDA inspection 1043309 of GlaxoSmithKline, LLC., January 26, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1043309
- Company Name: GlaxoSmithKline, LLC.
- Inspection Date: 2018-01-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1332910 - 2026-07-15
- [FDA Inspection 1274978 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/b8f525fd-c7f3-4be7-96cb-3b6521628f55)
- [FDA Inspection 1261906 - 2024-09-25](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/a2084345-5a0c-4a87-8363-0d2bd8669d45)
- FDA Inspection 1211050 - 2023-06-20
- FDA Inspection 927643 - 2015-05-08

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anita-r-michael/b7699b1a-4157-477e-8226-2cfc906fc61d)

Company: https://www.keypedia.com/companies/glaxosmithkline-llc/7ab59069-93ea-4898-a74a-874992c27286

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
